We are absolutely committed to all our COVID-19 vaccine trial participants who have selflessly volunteered to participate in our studies and were amongst the first in the world to receive the COVID vaccine. We plan to provide a third dose to all interested, eligible participants aged 16 years and over who remain in follow-up within the study. We are working on all the necessary elements that would allow this to be performed within the study and will provide an update to our participants as we progress this plan. If you are a patient in Pfizer’s COVID vaccine clinical study, you will be eligible for a booster shot. We will contact you to set up an appointment at the appropriate time.